Neurosense Therapeuti -CW23NRSNWPreferred / convertible
13F holders, Q2 2024 (June 30)4holders
1new positions
1sold out
1famous investor
$0.21avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Neurosense Therapeuti -CW23 (NRSNW) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were Clear Street LLC ($12K), Warberg Asset Management LLC ($7K) and Citadel Advisors ($6K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Neurosense Therapeuti -CW23
- CUSIP
- M74240116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $125 |
| Exits | 1 | $36K |
All 13F filers, Q1 2024 → Q2 2024: 705 shares bought and 114,827 shares sold, net −114,122 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Clear Street LLC | — | Add +0.2% | 59,272 | $12K |
| Warberg Asset Management LLC | — | Reduce -22.7% | 32,006 | $7K |
| Citadel Advisors | — | Reduce -38.8% | 29,464 | $6K |
| UBS Group AG | — | New | 605 | $125 |
"% of holder's portfolio" is NRSNW's weight in each manager's 13F, not the share of Neurosense Therapeuti -CW23 the manager owns.